These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Specific HLA antibody production following renal transplantation. Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885 [No Abstract] [Full Text] [Related]
5. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin. Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849 [No Abstract] [Full Text] [Related]
6. Pretransplantation plasmapheresis in HLA-sensitized patients: five years experience. Alarabi A; Backman U; Wikström B; Sjöberg O; Tufveson G Transplant Proc; 1995 Dec; 27(6):3448. PubMed ID: 8540045 [No Abstract] [Full Text] [Related]
7. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
8. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients. Suciu-Foca N; Ho E; King DW; Yu YP; Yu-Kai S; Reed E; Cohen D; Brensilver JM; McCabe R; Rose E Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536 [No Abstract] [Full Text] [Related]
9. Effect of simvastatin in the treatment of highly sensitized dialysis patients: the pre and post-renal transplantation follow-up outcomes. Nurhan Ozdemir F; Akcay A; Sezer S; Arat Z; Colak T; Turan M; Gulmus S; Haberal M Transpl Immunol; 2004; 13(1):39-42. PubMed ID: 15203127 [TBL] [Abstract][Full Text] [Related]
10. [Incidence of anti-HL-A antibodies in patients under dialysis and in a transplantation program in relation to rejection]. Erbenová E; Erben J Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1976; 19(3):303-9. PubMed ID: 801077 [No Abstract] [Full Text] [Related]
11. The rationale for plasmapheresis in renal graft rejection. Frascà G; Vangelista A; DiFelice A; D'Arcangelo GL; Sermasi G; Zucchelli P; Bonomini V Life Support Syst; 1984; 2(2):131-6. PubMed ID: 6384671 [TBL] [Abstract][Full Text] [Related]
12. [Plasmapheresis, immunosuppressive therapy and kidney transplant in a pre-sensitized patient]. Cuéllar-Cabrera H; Ramírez-Fernández M; Guerra-Rosales MJ; Sánchez-Avila MA Bol Med Hosp Infant Mex; 1989 Apr; 46(4):246-50. PubMed ID: 2655653 [TBL] [Abstract][Full Text] [Related]
13. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
14. Detection of anti-idiotypic antibodies to HLA (anti-anti-HLA antibodies) by use of human monoclonal antibodies. Pistillo MP; Ferrara GB; Reed E; Brensilver J; McCabe R; Benvensity A; Hardy M; King DW; Suciu-Foca N Transplant Proc; 1989 Feb; 21(1 Pt 1):760-1. PubMed ID: 2650260 [No Abstract] [Full Text] [Related]
15. Management of highly sensitized patients: capitol medical center experience. Amante AJ; Ejercito R Transplant Proc; 2008 Sep; 40(7):2274-80. PubMed ID: 18790211 [TBL] [Abstract][Full Text] [Related]